Matsui Ryota, Inaki Noriyuki, Tsuji Toshikatsu, Fukunaga Tetsu
Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital, Kanazawa 920-8201, Japan.
Department of Upper Gastrointestinal Surgery, Juntendo University Hospital, Tokyo 113-8431, Japan.
Cancers (Basel). 2024 Feb 19;16(4):833. doi: 10.3390/cancers16040833.
The purpose of this study was to investigate the association between preoperative inflammation and postoperative complications in gastric cancer patients having elective gastrectomy. Participants in this study were those who underwent radical gastrectomy between April 2008 and June 2018 and were diagnosed with stage I-III primary gastric cancer. Preoperative CRP values were used to divide the patients into two groups: the inflammation group comprised individuals having a CRP level of ≥0.5 mg/dL; the other was the non-inflammation group. The primary outcome was overall complications of Clavien-Dindo grade II or higher after surgery. Using propensity score matching to adjust for background, we compared the postoperative outcomes of the groups and conducted a multivariate analysis to identify risk variables for complications. Of 951 patients, 852 (89.6%) were in the non-inflammation group and 99 (10.4%) were in the inflammation group. After matching, both groups included 99 patients, and no significant differences in patient characteristics were observed between both groups. The inflammation group had a significantly greater total number of postoperative complications ( = 0.019). The multivariate analysis revealed that a preoperative CRP level of ≥0.5 mg/dL was an independent risk factor for total postoperative complications in all patients (odds ratio: 2.310, 95% confidence interval: 1.430-3.730, < 0.001). In conclusion, in patients undergoing curative resection for gastric cancer, preoperative inflammation has been found to be an independent risk factor for overall complications after surgery. Patients with chronic inflammation require preoperative treatment to reduce inflammation because chronic inflammation is the greatest risk factor for postoperative complications.
本研究旨在调查择期行胃切除术的胃癌患者术前炎症与术后并发症之间的关联。本研究的参与者为2008年4月至2018年6月期间接受根治性胃切除术且被诊断为I-III期原发性胃癌的患者。术前C反应蛋白(CRP)值用于将患者分为两组:炎症组包括CRP水平≥0.5mg/dL的个体;另一组为非炎症组。主要结局为术后Clavien-Dindo分级II级或更高的总体并发症。使用倾向评分匹配来调整背景因素,我们比较了两组的术后结局,并进行多变量分析以确定并发症的风险变量。951例患者中,852例(89.6%)在非炎症组,99例(10.4%)在炎症组。匹配后,两组各有99例患者,两组患者特征无显著差异。炎症组术后并发症总数显著更多(P=0.019)。多变量分析显示,术前CRP水平≥0.5mg/dL是所有患者术后总体并发症的独立危险因素(优势比:2.310,95%置信区间:1.430-3.730,P<0.001)。总之,在接受胃癌根治性切除的患者中,术前炎症已被发现是术后总体并发症的独立危险因素。患有慢性炎症的患者需要术前治疗以减轻炎症,因为慢性炎症是术后并发症的最大危险因素。